AristaCare at Manchester: Drug Storage Violations - NJ
The drug storage violation, cited under a category covering pharmacy service deficiencies, found that the facility failed to ensure medications and biological agents were properly labeled and kept in locked compartments, with controlled substances stored in separately locked areas. Inspectors rated the deficiency at Scope/Severity Level D, meaning the problem was isolated and did not produce documented harm to any resident, but carried the potential for more than minimal harm.
That distinction matters. Controlled substances sitting in unlocked or improperly secured storage are accessible in ways they should not be. Medications without proper labeling can be misidentified. In a facility where residents depend on staff to administer the right drug at the right dose at the right time, a breakdown in the chain of custody between the pharmacy and the bedside is not a paperwork problem.
The inspection was triggered by a complaint, not a routine survey cycle. That means someone, a resident, a family member, or a staff member, contacted regulators with a concern serious enough to prompt a visit. The August 27 inspection produced seven cited deficiencies in total. The drug storage finding was one of them.
AristaCare at Manchester reported that the violation was corrected as of October 21, 2025, nearly two months after inspectors documented the problem. Whether that correction involved securing storage units, relabeling medications, retraining pharmacy staff, or some combination of those steps is not detailed in the inspection record.
What the record does show is the gap. Inspectors arrived, found medications not stored or labeled as they should be, and left a facility with a deficiency citation and a deadline to fix it. The facility met that deadline, according to its own reported correction date. Federal inspectors have not yet confirmed independent verification of that correction in the materials reviewed.
AristaCare operates multiple facilities across New Jersey. The Manchester location serves residents who, by the nature of nursing home care, are typically managing multiple chronic conditions and complex medication regimens. The average nursing home resident takes several medications daily. The systems meant to ensure those medications are the right ones, stored securely and identified accurately, exist precisely because the consequences of failure fall on people who are already vulnerable.
A Level D deficiency is the lowest severity tier that still carries a finding of potential harm. It is not a warning or an advisory. It is a formal citation that becomes part of the facility's permanent federal inspection record and factors into the star ratings the Centers for Medicare and Medicaid Services publishes for every certified nursing home in the country.
Seven deficiencies in a single complaint inspection is a number worth noting. The pharmacy finding was one piece of a larger picture inspectors documented that day. The other six deficiencies cited during the same visit are not detailed in the materials provided for this report.
The facility's correction date of October 21 means residents lived with whatever conditions inspectors found for nearly eight weeks before the facility declared the problem resolved. That is the timeline the record reflects.
Full Inspection Report
The details above represent a summary of key findings. View the complete inspection report for Aristacare At Manchester LLC from 2025-08-27 including all violations, facility responses, and corrective action plans.
Additional Resources
Data source: This article is based on inspection data downloaded directly from the Centers for Medicare & Medicaid Services (CMS) via Medicare.gov. CMS releases inspection reports in bulk; we publish the findings as documented by state surveyors in the official Form CMS-2567 Statement of Deficiencies.
Plan of correction: The CMS report we receive does not include the facility's plan of correction. Facilities submit plans of correction separately to state survey agencies and those responses may not be reflected in CMS data at the time of publication. The absence of a plan of correction in our data does not mean one was not filed. Readers who want information about corrective steps taken are encouraged to contact the facility directly or their state survey agency.
Corrections may have occurred: Inspection reports reflect conditions observed on the date of the survey. Facilities may have implemented corrections, staffing changes, additional training, or other remediation since the report was issued. We report what CMS provides and encourage readers to seek current information from the facility.
Editorial process: Inspection findings are extracted from CMS source documents and synthesized using AI, reviewed for factual accuracy against the original report by our editorial team.
Professional review: All content reviewed by Christopher F. Nesbitt, Sr., NH EMT & BU-trained Paralegal.
Last verified: October 3, 2026 · Our methodology
AristaCare at Manchester LLC in MANCHESTER, NJ was cited for violations during a health inspection on August 27, 2025.
Controlled substances sitting in unlocked or improperly secured storage are accessible in ways they should not be.
Health inspections identify deficiencies that facilities must correct. Violations range from minor documentation issues to serious safety concerns. Review the full report below for specific details and facility response.